Wall Street brokerages expect MAXIMUS, Inc. (NYSE:MMS) to announce earnings per share of $0.80 for the current quarter, according to Zacks. Four analysts have made estimates for MAXIMUS’s earnings. The highest EPS estimate is $0.83 and the lowest is $0.77. MAXIMUS reported earnings per share of $0.78 during the same quarter last year, which would suggest a positive year over year growth rate of 2.6%. The business is expected to issue its next quarterly earnings results on Thursday, February 14th.
On average, analysts expect that MAXIMUS will report full-year earnings of $3.66 per share for the current financial year, with EPS estimates ranging from $3.57 to $3.71. For the next year, analysts expect that the business will report earnings of $4.05 per share, with EPS estimates ranging from $3.83 to $4.21. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that cover MAXIMUS.
MAXIMUS (NYSE:MMS) last announced its earnings results on Tuesday, November 20th. The health services provider reported $0.71 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The business had revenue of $558.50 million for the quarter, compared to the consensus estimate of $587.58 million. MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. The firm’s revenue for the quarter was down 10.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.81 earnings per share.
A number of research analysts recently issued reports on MMS shares. Canaccord Genuity lifted their price objective on shares of MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research note on Wednesday, October 10th. Zacks Investment Research raised shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a research note on Friday, November 23rd. Finally, ValuEngine raised shares of MAXIMUS from a “hold” rating to a “buy” rating in a research note on Friday, November 30th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. MAXIMUS presently has a consensus rating of “Buy” and an average price target of $72.00.
NYSE:MMS traded down $0.52 during mid-day trading on Friday, reaching $69.86. The stock had a trading volume of 660,408 shares, compared to its average volume of 432,378. The stock has a market capitalization of $4.51 billion, a price-to-earnings ratio of 20.55, a price-to-earnings-growth ratio of 1.92 and a beta of 1.03. MAXIMUS has a 12 month low of $60.00 and a 12 month high of $72.71.
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 30th. Investors of record on Thursday, November 15th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.43%. This is a boost from MAXIMUS’s previous quarterly dividend of $0.05. The ex-dividend date was Wednesday, November 14th. MAXIMUS’s dividend payout ratio (DPR) is 29.41%.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $63.86, for a total transaction of $63,860.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Vice Chairman Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $72.03, for a total transaction of $2,160,900.00. Following the sale, the insider now directly owns 429,874 shares in the company, valued at approximately $30,963,824.22. The disclosure for this sale can be found here. Insiders sold 133,124 shares of company stock worth $9,005,450 over the last three months. 3.10% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of MMS. TD Asset Management Inc. grew its stake in shares of MAXIMUS by 178.4% during the second quarter. TD Asset Management Inc. now owns 55,400 shares of the health services provider’s stock worth $3,441,000 after buying an additional 35,500 shares during the last quarter. Smith Asset Management Group LP grew its stake in shares of MAXIMUS by 92.5% during the second quarter. Smith Asset Management Group LP now owns 28,860 shares of the health services provider’s stock worth $1,792,000 after buying an additional 13,870 shares during the last quarter. Wells Fargo & Company MN grew its stake in shares of MAXIMUS by 299.9% during the second quarter. Wells Fargo & Company MN now owns 919,740 shares of the health services provider’s stock worth $57,124,000 after buying an additional 689,734 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of MAXIMUS during the second quarter worth $691,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in shares of MAXIMUS during the second quarter worth $1,094,000. 93.29% of the stock is currently owned by hedge funds and other institutional investors.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Featured Article: Why is the ex-dividend date different from the record date?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.